Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapies to treat substance use disorders and drug overdose.

Addiction is not a character flaw – it is now recognized as a chronic brain disease with the potential for both recovery and relapse, and we must treat it with the same skill and compassion with which we approach heart disease, diabetes, and cancer (2016 Surgeon General’s Report). It is the most severe manifestation of a substance use disorder (SUD), characterized by significant impairments in health, social function and control over substance use.  Similar to other chronic brain diseases, addiction can and should be treated with medications alongside supportive therapy when appropriate.

In response to this growing public health crisis, Opiant is developing a robust clinical pipeline of products to treat substance use disorders and drug overdose.

Opiant CEO Roger Crystal Testifies Before the President’s Commission

September 27, 2017 – Opiant CEO Dr. Roger Crystal testifies before the President’s Commission on Combating Drug Addiction and the Opioid Crisis.

Opiant CEO Roger Crystal on Fox and Friends

April 11, 2019 – Opiant CEO Dr. Roger Crystal discusses treating opioid addiction with medical marijuana.

Opiant CEO Roger Crystal on Fox Business Network’s “Mornings with Maria”

August 3, 2018 – Opiant CEO Dr. Roger Crystal discusses Narcan following singer Demi Lovato’s hospitalization.